Avellino Corneal Dystrophy After LASIK
Total Page:16
File Type:pdf, Size:1020Kb
Avellino Corneal Dystrophy after LASIK Roo Min Jun, MD,1,4 Hungwon Tchah, MD,2 Tae-im Kim, MD,2 R. Doyle Stulting, MD, PhD,3 Seung Eun Jung, MS,4,6 Kyoung Yul Seo, MD,4 Dong Ho Lee, MD,5 Eung Kweon Kim, MD, PhD4,6 Objective: To report cases of Avellino corneal dystrophy (ACD) exacerbated by LASIK for myopia. Design: Retrospective, noncomparative, interventional case series and review of the literature. Participants: Seven patients. Intervention: Six patients with exacerbation of granular corneal deposits after LASIK were examined for TGFBI mutations by polymerase chain reaction sequencing of DNA. One previously reported patient who was heterozygous for the ACD gene was followed up for 16 months after mechanical removal of granular deposits from the interface after LASIK. Main Outcome Measures: Slit-lamp examination, visual acuity, manifest refraction, and DNA sequencing analysis. Results: All patients were heterozygous for the Avellino dystrophy gene. Corneal opacities appeared 12 months or more after LASIK. Best spectacle-corrected visual acuity decreased as the number and density of the opacities increased. One patient underwent mechanical removal of granules from the interface and had a severe recurrence within 16 months. Another patient had removal of the granules from the interface with PTK, followed by treatment with topical mitomycin C. In this patient, the cornea has remained relatively clear for 6 months. Conclusions: Laser in situ keratomileusis increases the deposition of visually significant corneal opacities and is contraindicated in patients with ACD. Mechanical removal of the material from the interface does not prevent further visually significant deposits. Mitomycin C treatment, in conjunction with surgical removal of opacities, may be an effective treatment. Ophthalmology 2004;111:463–468 © 2004 by the American Academy of Ophthalmology. Avellino corneal dystrophy (ACD) is an autosomal domi- generally is slow, and good visual acuity is maintained until nant dystrophy with clinical features of both granular and later life despite an increasing number of granular opacities lattice dystrophy. Originally described in patients from in the cornea. Patients with homozygous ACD typically Avellino, Italy, it has now been reported around the have an earlier onset of visual symptoms and granular world.1–5 opacities, with increasing latticelike deposits in later life.1,11 Its appearance is variable, and it is often misdiagnosed as We recently reported a patient with heterozygous ACD granular dystrophy.6–8 The diagnosis can be confirmed by in whom corneal deposits increased after LASIK.12 In that genetic analysis, demonstrating the replacement of histidine case report, the deposits appeared in the interface and were by arginine at codon 124 of the TGFBI gene.9,10 In patients removed 21 months after LASIK, with an improvement in with heterozygous ACD, the deposition of corneal opacities best spectacle-corrected visual acuity (BSCVA).12 The purpose of this study was to report 6 additional Originally received: March 21, 2003. patients with ACD who underwent LASIK and to provide Accepted: June 25, 2003. Manuscript no. 230164. additional follow-up on the previously reported patient. 1 Department of Ophthalmology, Ewha Womans University College of Medicine, Seoul, Korea. 2 Department of Ophthalmology, University of Ulsan, College of Medi- cine, Seoul, Korea. Patients and Methods 3 Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. Seven patients with white granular opacities in the interface be- 4 tween the flap and stromal bed after uneventful LASIK are the Institute of Vision Research, Department of Ophthalmology, Yonsei subjects of this report. Preoperative characteristics of each and University College of Medicine, Seoul, Korea. details of the surgeries are shown in Table 1. 5 Yonsei Eye Center, Seoul, Korea. DNA analysis was performed from peripheral blood as previ- 6 The Brain Korea 21 Project for Medical Science, Yonsei University, ously described.12 The TGFBI gene was analyzed by sequencing Seoul, Korea. exon 4 for ACD (R124H mutation) and exon 12 for granular Supported by a grant of the Korea Health 21 R&D Project, Ministry of corneal dystrophy (R555W mutation). The primer pairs used to Health & Welfare, Republic of Korea (grant no.: 02-PJ1-PG1-CH02-0003). amplify the 2 exons were purified with a polymerase chain reaction The authors have no proprietary interests. purification kit (Qiagen, Hilden, Germany) and were sequenced Correspondence to Eung Kweon Kim, MD, PhD, Department of Ophthal- with an automatic fluorescent DNA sequencer (ABI Prism 377; mology, Yonsei University College of Medicine, Seodaemoongu Shin- Applied Biosystems, Foster City, CA) and a dry terminator cycle chondong 134, C.P.O. Box 8044, Seoul, Korea. E-mail: sequencing kit (Perkin Elmer, Foster City, CA). All 7 patients were [email protected]. heterozygous for the ACD gene. © 2004 by the American Academy of Ophthalmology ISSN 0161-6420/04/$–see front matter 463 Published by Elsevier Inc. doi:10.1016/j.ophtha.2003.06.026 Ophthalmology Volume 111, Number 3, March 2004 Table 1. Clinical Characteristics of Patients with Recurrent Avellino Corneal Dystrophy after LASIK Refractive Error before LASIK Detection Best Spectacle-corrected Eyes Treated (Spherical Deposits before Duration of Visual Acuity after No Gender Age* with LASIK Equivalent) LASIK Microkeratome Excimer Laser Recurrence† Recurrence 1 M 27 Both Right, Ϫ9.25 Unknown ACS Mel 60 14 mo 20/30 Left, Ϫ9.50 Unknown 20/50 2 F 22 Left Right, Ϫ6.75 Yes SCMD VISX 20/20 Ͻ5 yrs No operation Left, Ϫ10.75 Yes 20/100 3 F 28 Both Right, Ϫ3.50 Yes SCMD VISX S2 Ͻ4 yrs 20/40 Left, Ϫ5.25 Yes 20/20 4 F 32 Both Right, Ϫ10.25 Yes Moria C&B Nidek EC5000 Ͻ2 yrs 20/20 Left, Ϫ8.75 Yes 20/20 5 F 27 Both Right, Ϫ9.75 Yes ACS Telco 13 mos 20/30 Left, Ϫ9.88 Yes 20/30 6 F 27 Both Right, Ϫ9.50 Yes ACS VISX S2 12 mos 20/25 Left, Ϫ8.50 Yes 20/25 7 F 22 Both Right, Ϫ3.00 Yes ACS Kerator 217 12 mos 20/30 Left, Ϫ3.00 Yes 20/30 ACS, Automated Corneal Shaper (Bausch & Lomb Surgical, Claremont, CA); Kerator 217, Kerator 217 excimer laser (Bausch & Lomb Surgical, Claremont, CA); Mel 60, Meditec MEL 60 excimer laser (Aesculap-Meditec, Heroldsberg, Germany); Moria C&B, Moria C&B (Moria Surgical, Antony, France); Nidek EC5000, Nidek EC5000 (Nidek, Gamagori, Japan); SCMD, SCMD manual microkeratome (SCMD, Doylestown, PA); VISX 20/20, VISX 20/20 (VISX Excimer Laser System, Santa Clara, CA); VISX S2, VISX Star S2 (VISX Excimer Laser System, Santa Clara, CA); Telco, Telco (Telco Medical Technologies, Perth, Australia). *Age at which LASIK surgery was performed. †The time of appearance of deposits in patients 2, 3, and 4 is not certain, because they were not examined for several years after LASIK. This study was performed in accordance with the Helsinki Before LASIK, MR was Ϫ6.00 Ϫ1.50ϫ180 in the right eye Agreement, and informed consent was obtained from all subjects. and Ϫ9.50 Ϫ2.50ϫ5 in the left eye, yielding 20/20 in the right eye and 20/25 in the left eye. A few granular corneal opacities were observed before LASIK in both eyes. Surgery was performed Patient 1 uneventfully, and uncorrected visual acuity in the left eye was A 33-year-old Korean male underwent LASIK in 1996. An oph- 20/25 4 months after LASIK. The ethics committee of that hospital thalmic examination performed 6 years previously did not docu- prohibited the surgeon from performing LASIK on the opposite ment corneal opacities. Manifest refraction (MR) before LASIK eye because of the appearance of granular opacities in the operated was Ϫ9.00 Ϫ0.50ϫ90 in the right eye and Ϫ9.50 in the left eye, eye. yielding 20/20 in the right eye and 20/25 in the left eye. Fourteen In January 2002, the patient noted blurred vision in the left eye. months after surgery, the surgeon noted white opacities in the On presentation, there were several discrete granular opacities in interface between the flap and the residual stromal bed in both the anterior stroma of right cornea. Manifest refraction and eyes, even though the BSCVA was 20/20 in both eyes. The patient BSCVA of the right eye were unchanged from 5 years previously. (Fig 1) visited another physician, who removed some of the In the operated left cornea, numerous dense, confluent granular opacities from the interface of the left cornea on September 9, opacities were noted centrally in the interface between the flap and 2002. residual stroma (Fig 2). Manifest refraction was Ϫ1.50 in the left On presentation on October 24, 2002, granular deposits were eye, yielding 20/100 BSCVA. observed centrally in the interface beneath the flap of both eyes, more numerous in the right than the left. Manifest refraction was Ϫ3.25 Ϫ0.50ϫ40 in the right eye and Ϫ2.50 Ϫ1.00ϫ90 in the left Patient 3 eye, yielding 20/30 in the right eye and 20/40 in the left eye. His 61-year-old father and 1 of his 2 sisters had corneal A 32-year-old Korean female was referred in July 2002 with opacities consistent with ACD. Another surgeon had declined to decreased visual acuity in her right eye. She had undergone LASIK perform LASIK on that sister with ACD 4 years previously at her in both eyes 4 years previously, without complications. Several age of 26 because white granules were observed in the corneal granular corneal opacities had been observed in both eyes before stroma. That same surgeon performed LASIK on the other sister, surgery. Two years after LASIK, she noted progressive loss of who was 24 years old at the time, because no stromal opacities vision.